Gene Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 PosttranslationalModification disease BEFREE Aberrant p16 methylation was found in 23 of 60 (38%) primary gastric cancers, but in none of the corresponding gastric mucosae. 12824886 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 PosttranslationalModification disease BEFREE The results suggest that hypermethylation and abnormality of p16 gene may play a key role in the progress of gastric cancer. 12632489 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 PosttranslationalModification disease BEFREE The objective of this study was to investigate the contribution of p16 inactivation in gastric cancer and to compare it with p53. 12469165 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 GeneticVariation disease BEFREE The frequencies of LOH in two microsatellite sites, D9s171 and D9s1604, in p16 genome were associated with development of gastric cancer and no significant correlation was demonstrated between the LOH frequency and the cell differentiated types of tumor cells or clinical stages. 12632492 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 Biomarker disease BEFREE To investigate the expression of human telomerase reverse transcriptase gene (hTRT) in gastric cancer (GC) and its relevance with cell cycle regulators including P16INK4, cyclin and P53. 12632490 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 PosttranslationalModification disease BEFREE p16(INK4a) and p14(ARF) genes are frequently inactivated by homozygous deletion and methylation of the 5'CpG islands in gastric cancer, which may play an important role in the carcinogenesis of gastric cancer. 12890389 2003
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 AlteredExpression disease BEFREE The overexpression of p16 seems to be a common event in the development of both intestinal and diffuse type of gastric cancer and it is likely that it may be driven by features of the neoplastic state. 12145426 2002
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 Biomarker disease BEFREE These results suggest that p16(INK4a) promoter hypermethylation is an early and frequent event in gastric carcinogenesis and may serve as a new prognostic biomarker for the risk of gastric cancers. 11477571 2001
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 GeneticVariation disease BEFREE Expression, deletion [was deleton] and mutation of p16 gene in human gastric cancer. 11819820 2001
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 Biomarker disease BEFREE In an effort to explore the underlying mechanism for the p16(INK4)-negative cases, a prospective study was also performed on 20 cases of gastric cancer to compare the level of the p16(INK4) protein with the methylation status of the p16(INK4) promoter. 10705239 2000
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 Biomarker disease BEFREE In the present study, we investigated the 5' CpG island hypermethylation of hMLH1, E-cadherin and p16 in 61 primary gastric cancers (GCs) by using combined bisulfite restriction analysis (COBRA) and methylation-specific PCR (MSP), and their MSI status. 10495421 1999
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 AlteredExpression disease BEFREE Therefore, alteration and heterozygous expression of CDKN2 appears to be involved in the pathogenesis of human gastric cancers. 9139866 1997
Entrez Id: 1029
Gene Symbol: CDKN2A
CDKN2A
0.400 GeneticVariation disease BEFREE Intragenic homozygous deletions of MTS1 gene in gastric cancer in Taiwan. 8957063 1996